Skip to main content
. 2019 Mar 12;59(2):755–766. doi: 10.1007/s00394-019-01942-5

Table 5.

IF concentrations at baseline and following 12 weeks’ soy drink intervention

Treatment group Low Medium High
Baseline (n = 32) Week 12 (n = 32) Baseline (n = 35) Week 12 (n = 32) Baseline (n = 28) Week 12 (n = 23)
Genistein (ng/ml) 10.01 ± 22.07a 82.75 ± 124.62A 9.83 ± 24.25 168.71 ± 166.81B 6.40 ± 9.27 216.71 ± 305.36B
Daidzein (ng/ml) 5.03 ± 11.88 20.44 ± 30.82A 2.29 ± 4.37 39.20 ± 36.9B 2.50 ± 3.34 49.82 ± 66.49B
Equol (ng/ml) 1.76 ± 6.01 3.81 ± 8.17A BLD 9.43 ± 19.84A 0.42 ± 1.30 11.69 ± 19.23A

BLD below limit of detection

aMean ± SD (all such values)

A,BValues with different superscript letters across a row are significantly different (Kruskal–Wallis with post hoc Mann–Whitney U test)